
R J Medipharma Private Limited
About R J Medipharma Private Limited
Data last updated:
R J Medipharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U33111UP2011PTC043710. Its GSTIN is 09AAFCR3973F1Z4 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rama Jaiswal and Rajjan Lal Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kanpur, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.49 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹43.37 Lakh (net margin 9.7%) and EBITDA of ₹63.9 Lakh (EBITDA margin 14.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over five years.
As per MCA filings, the company has open charges of ₹70 Lakh and satisfied charges of ₹70 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
R J Medipharma Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 59 II Floor, Bima Vihar Colony Lakhanpur, Kanpur, Uttar Pradesh, India – 208024
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of R J Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of R J Medipharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of R J Medipharma Private Limited, buy the company report.
Financials of R J Medipharma Private Limited
FY 2025 filings availableR J Medipharma Private Limited reported revenue of ₹4.49 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 12% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹63.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.2% | ||||
| Net Profit Margin | 9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of R J Medipharma Private Limited, buy the company report.
Board of directors of R J Medipharma Private Limited
R J Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Jaiswal | Director | 23 Feb 2011 | 15 Years 8 Months | Current |
| Rajjan Lal Jaiswal | Director | 23 Feb 2011 | 15 Years 8 Months | Current |
Peer comparison
R J Medipharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nutrizone Industries Private Limited | ₹4.5 Cr (FY 2022) | 397.0% | Barrackpore, West Bengal, India | |||
| Corporate Chain Private Limited | ₹4.5 Cr (FY 2019) | 22.0% | Ahmedabad, Gujarat, India | |||
| Aura Agencies Private Limited | ₹4.49 Cr (FY 2025) | 17.0% | Kolkata, West Bengal, India | |||
| R J Medipharma Private Limitedthis company | ₹4.49 Cr (FY 2025) | ₹43.37 Lakh | 9.7% | 12.0% | Kanpur, Uttar Pradesh, India | |
| Genoviq Healthcare Private Limited | ₹4.49 Cr (FY 2024) | -44.0% | Mumbai, Maharashtra, India | |||
| Trademed India Private Limited | ₹4.48 Cr (FY 2024) | -31.0% | Lucknow, Uttar Pradesh, India | |||
| Bioethics Lifesciences Private Limited | ₹4.48 Cr (FY 2025) | 11.0% | Ambala Cantt, Haryana, India |
To see the full peer comparison of R J Medipharma Private Limited, buy the company report.
Auditor
R J Medipharma Private Limited is audited by JAUHARI GUPTA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAUHARI GUPTA AND ASSOCIATES | FY 2023 | 012910C |
Shareholding
The shareholding of R J Medipharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of R J Medipharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2023 | 100776200 | Indian Bank | ₹20 Lakh | Satisfied | |
| 25 Jan 2022 | 100535639 | Indian Bank | ₹50 Lakh | Satisfied |
To see the full charge records of R J Medipharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving R J Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
R J Medipharma Private Limited has 8 MSME Form 1 returns on record between 2019 and 2023, listing 129 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Park Pharmaceuticals | |||
| Park Pharmaceuticals | |||
| Heartsring Medipharma Private Limited |
To see the full MSME payment records of R J Medipharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
R J Medipharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCR3973F1Z4 | Uttar Pradesh | Active | 18 Sep 2017 |
To see the full GST registrations and return filing status of R J Medipharma Private Limited, buy the company report.
Recent activity
R J Medipharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Rajjan Lal Jaiswal was appointed as Director on 23 Feb 2011.
Frequently asked questions
R J Medipharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 February 2011 (15+ years old) and is registered under CIN U33111UP2011PTC043710.
R J Medipharma has 2 current directors:
- Rama Jaiswal - Director
- Rajjan Lal Jaiswal - Director
The latest financial statements of R J Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of R J Medipharma is 09AAFCR3973F1Z4, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of R J Medipharma is U33111UP2011PTC043710. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R J Medipharma was incorporated on 23 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of R J Medipharma by revenue are Nutrizone Industries Private Limited, Corporate Chain Private Limited, Aura Agencies Private Limited, Genoviq Healthcare Private Limited, Trademed India Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajjan Lal Jaiswal was appointed as Director on 23 Feb 2011. Rama Jaiswal was appointed as Director on 23 Feb 2011.
R J Medipharma has 8 MSME Form 1 returns on record between 2019 and 2023, listing 129 overdue payments to 3 micro and small suppliers. The latest return was filed on 15 Nov 2023.
The registered office of R J Medipharma is at C – 59 II Floor, Bima Vihar Colony Lakhanpur, Kanpur, Uttar Pradesh, India – 208024.
R J Medipharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
R J Medipharma has open charges of ₹70 Lakh and satisfied charges of ₹70 Lakh as per latest MCA filings.

